Literature DB >> 12737508

Normalisation of visual evoked potentials after optic neuritis.

Rudy R Hidajat1, David H Goode.   

Abstract

Normalisation of the visual evoked potential (VEP) in patients with optic neuritis (ON) appears to be a rare phenomenon. However, although several workers have indicated that it can happen, they have not followed up with subsequent VEP tests to confirm how long the VEP latency of the affected eye remains in the normal range. To resolve this, 18 patients with a clinical diagnosis of acute unilateral ON were followed for 5 years with repeated VEP tests to determine if the latency of the P2 wave from affected eye could return to the normal range. Furthermore, in cases where the latency returned to normal, the length of time that it remained so was also assessed. The normal range for the latency of the P2 wave was determined by measuring VEPs from a group of 18 healthy control subjects with a similar age distribution to the patients. This established an upper limit of 115.9 ms. At presentation the mean P2 latency of the affected eyes of the patients was 140 ms with a standard deviation of 16 ms. In general, the VEP latencies remained constant over the period of the investigation. However two patients demonstrated a return to normal latencies but this was only temporary. Their latencies become prolonged again within 2 years. These results provide evidence that the delayed P2 latency observed in patients with ON can return to the normal range in a small percentage of cases. However, this improvement may spontaneously deteriorateonce more as a result of further episodes of subacute demyelination.

Entities:  

Mesh:

Year:  2003        PMID: 12737508     DOI: 10.1023/a:1022973100421

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  15 in total

1.  Visual evoked responses in the diagnosis and management of patients suspected of multiple sclerosis.

Authors:  P Asselman; D W Chadwick; D C Marsden
Journal:  Brain       Date:  1975-06       Impact factor: 13.501

2.  Serial visual evoked potentials in 90 untreated patients with acute optic neuritis.

Authors:  J L Frederiksen; J Petrera
Journal:  Surv Ophthalmol       Date:  1999-10       Impact factor: 6.048

3.  Visual evoked responses and ophthalmological examination in optic neuritis. A follow-up study.

Authors:  M A Hely; P G McManis; J C Walsh; J G McLeod
Journal:  J Neurol Sci       Date:  1986-10       Impact factor: 3.181

4.  Delayed visual evoked response in optic neuritis.

Authors:  A M Halliday; W I McDonald; J Mushin
Journal:  Lancet       Date:  1972-05-06       Impact factor: 79.321

Review 5.  Pathophysiology of demyelinating disease.

Authors:  A M Halliday; W I McDonald
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

6.  Serial recording of visual and somatosensory evoked potentials in multiple sclerosis.

Authors:  W B Matthews; D G Small
Journal:  J Neurol Sci       Date:  1979-01       Impact factor: 3.181

7.  Optic neuritis and multiple sclerosis.

Authors:  G C Ebers
Journal:  Arch Neurol       Date:  1985-07

8.  Prolonged follow-up of abnormal visual evoked potentials in multiple sclerosis: evidence for delayed recovery.

Authors:  W B Matthews; M Small
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-07       Impact factor: 10.154

9.  Pupil size and the pattern evoked visual response.

Authors:  C H Hawkes; B Stow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-01       Impact factor: 10.154

10.  Recovery after optic neuritis in childhood.

Authors:  A Kriss; D A Francis; F Cuendet; A M Halliday; D S Taylor; J Wilson; J Keast-Butler; J R Batchelor; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-10       Impact factor: 10.154

View more
  4 in total

1.  The value of VEP in the diagnosis and post-operative monitoring of meningioma.

Authors:  Rudy R Hidajat; Jan L McLay; David H Goode; J Ray Hidayat
Journal:  Doc Ophthalmol       Date:  2006-10-04       Impact factor: 2.379

2.  Assessing visual pathway function in multiple sclerosis patients with multifocal visual evoked potentials.

Authors:  Michal Laron; Han Cheng; Bin Zhang; Jade S Schiffman; Rosa A Tang; Laura J Frishman
Journal:  Mult Scler       Date:  2009-12-07       Impact factor: 6.312

3.  Electroretinographic improvement after rituximab therapy in a patient with autoimmune retinopathy.

Authors:  Gunay Uludag; Sumru Onal; Serra Arf; Isil Sayman Muslubas; Fatih Selcukbiricik; Aylin Koc Akbay; Nil Molinas Mandel
Journal:  Am J Ophthalmol Case Rep       Date:  2016-03-30

Review 4.  Clinical electrophysiology of the optic nerve and retinal ganglion cells.

Authors:  Oliver R Marmoy; Suresh Viswanathan
Journal:  Eye (Lond)       Date:  2021-06-11       Impact factor: 3.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.